Virus-HIV
Conditions
Brief summary
Since the advent of antiretroviral treatments, the life expectancy of people living with HIV (PLHIV) has increased significantly. In France, more than 30% of PLHIV are now over 50 years old. This population is exposed to high multimorbidity, leading to frequent polypharmacy, defined as the regular use of at least five medications. Polypharmacy also has a qualitative dimension, including potentially inappropriate prescriptions. It increases the risk of adverse effects and drug interactions and impairs quality of life. A coordinated geriatric approach is therefore essential to optimize care. Healthy aging, promoted by the WHO, aims to improve the lives of older people. In this context, a study will be conducted at the Nice University Hospital among PLHIV aged 75 and over. It will collect quantitative data, the results of which will enable us to consider, if necessary, adapting the care pathways of these patients whose needs are complex.
Interventions
OTHERinterview with advanced practice nurse
45 to 60 minutes of interview
Sponsors
Centre Hospitalier Universitaire de Nice
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
75 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* HIV-positive * Aged 75 or over * Affiliated with the social security system * Having expressed no objection to participating in the study
Exclusion criteria
* Refusal to participate * Known severe cognitive impairment preventing the interview from being conducted * Patient under guardianship or conservatorship
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Describe polypharmacy among people living with HIV aged 75 and older. | 15 months | The average number of medications taken |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Assess the most common comorbidities associated with polypharmacy in the population of PLHIV aged 75 | 15 months | Number et type of comorbidities |
| Assess whether people taking multiple medications have a lower treatment adherence score than those taking fewer medications. | 15 months | Score obtained on the Morisky MMAS-8 questionnaire |
| Assess the level of functional independence in this age group and link it to the existence of polypharmacy. | 15 months | Lawton and Brody IADL scale |
Countries
France
Outcome results
None listed